Skip to main content
Equibles

Daniel Bronder

Analyst

Cantor Fitzgerald

Equibles does not estimate personal net worth.

About Daniel Bronder

Daniel Bronder is recorded as Analyst at Cantor Fitzgerald. Daniel Bronder has spoken on 1 investor event across 1 company, most recently for Kura Oncology, Inc. on April 17, 2026. The companies whose calls Daniel Bronder spoke on are classified in the Healthcare sector.

Daniel Bronder on recent calls

“Could you elaborate on the 10 patients of the 18 that you had noticed had disease progression on prior CARBO, and what were the reasons the other patients discontinued CARBO, and whether or not you see responses across the whole spectrum of prior CARBO exposure?”
Analyst — Cantor Fitzgerald, Kura Oncology IKCS Virtual Investor Event ·

Affiliation history

  • Cantor Fitzgerald

    Analyst

    Transcript header (unverified)

    Current

Company network

Recent activity